s6y
Company name or ticker
Search
Nautilus Biotechnology, Inc.
4
Akinsanya Karen: Statement of changes in beneficial ownership of securities
Filed
Thursday, March 31, 2022
Period
Mar 30, 2022
Accession number
0001808805-22-000033
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header